Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic and Predictive Impact of Circulating Tumor DNA in Advanced and Localized Gastric Cancer Treatment

NCT02674373 is registered in ClinicalTrials.gov with Association des Gastroentérologues Oncologues as lead sponsor.

NCT NCT02674373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02674373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic and Predictive Impact of Circulating Tumor DNA in Advanced and Localized Gastric Cancer Treatment
Lead sponsor
Association des Gastroentérologues Oncologues
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2015
Completion date
September 30, 2019
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer